|
Membership
Application Membership Brochure |
| IMT Council Chairman: Michael
Reitermann Henry Hummel Anwer
Rizvi Ex
Officio: R.
Edward Coleman, M.D. |
||
 |
||
The
Institute for Molecular Technologies
Bringing the benefits of molecular imaging into
focus.
There is no question that advanced molecular imaging modalities such as PET and PET/CT have made a dramatic difference for patients with cancer, cardiac disease and neurological disorders. Today, PET is covered by Medicare and many private payor organizations for all the leading cancers, as well as cardiac disease and epilepsy. Yet there is much more that PET and PET/CT can do towards the diagnosis, staging and treatment of disease, and Medicare coverage and reimbursement play a critical role in how these advanced modalities are implemented by the healthcare community.
The Institute for Molecular Technologies (IMT) was created to help educate healthcare professionals, policy makers, the administration and the public on the value of advanced molecular imaging, with a particular focus on PET and PET/CT. And while AMI provides the framework, IMT is a powerful institute with its own organization and governing structures. According to its bylaws:
IMT's purpose is to sponsor and promote educational efforts to medical and science professionals, patients and the public, Congress, and government agencies in support of the clinical and research activities of AMI.
IMT Members are eligible for elective AMI offices. Two seats on the AMI Board are allocated to IMT members.
Membership Benefits > Membership Brochure >Coming Soon
National Oncologic PET RegistryTo learn more about the National Oncologic PET Registry visit the NOPR Web site at www.cancerPETregistry.org for more information.